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A B S T R A C T
Glucose, chief metabolic support for cancer cell survival and growth, is mainly imported into cells by facilitated
glucose transporters (GLUTs). The increase in glucose uptake along with tumor progression is due to an incre-
ment of facilitative glucose transporters as GLUT1. GLUT1 prevents cell death of cancer cells caused by growth
factors deprivation, but there is scarce information about its role on the damage caused by glucose deprivation,
which usually occurs within the core of a growing tumor. In prostate cancer (PCa), GLUT1 is found in the most
aggressive tumors, and it is regulated by androgens. To study the response of androgen-sensitive and insensitive
PCa cells to glucose deprivation and the role of GLUT1 on survival mechanisms, androgen-sensitive LNCaP and
castration-resistant LNCaP-R cells were employed. Results demonstrated that glucose deprivation induced a
necrotic type of cell death which is prevented by antioxidants. Androgen-sensitive cells show a higher resistance
to cell death triggered by glucose deprivation than castration-resistant cells. Glucose removal causes an incre-
ment of H2O2, an activation of androgen receptor (AR) and a stimulation of AMP-activated protein kinase ac-
tivity. In addition, glucose removal increases GLUT1 production in androgen sensitive PCa cells. GLUT1 ectopic
overexpression makes PCa cells more resistant to glucose deprivation and oxidative stress-induced cell death.
Under glucose deprivation, GLUT1 overexpressing PCa cells sustains mitochondrial SOD2 activity, compromised
after glucose removal, and significantly increases reduced glutathione (GSH). In conclusion, androgen-sensitive
PCa cells are more resistant to glucose deprivation-induced cell death by a GLUT1 upregulation through an
enhancement of reduced glutathione levels.
1. Introduction
Cancer cells usually show different metabolic requirements than
healthy cells to satisfy the higher demand aimed for proliferation. This
evidence was first described by Otto Warburg in the 20's, and it is al-
ready considered as one of the hallmarks of cancer [1,2]. Tumor cells
usually increase their nutrients uptake, mainly glucose and glutamine.
The increase in glycolytic flux, independent of oxygen concentration
(i.e. “aerobic glycolysis”), is employed to obtain NADPH as well as the
required precursors for biosynthesis [3].
Besides the promotion of cell proliferation, glucose metabolism
protects from cell death. Thus, an increase in glycolytic flux turn cells
into a more resistant phenotype to apoptosis [4]. The inhibition of cell
metabolism by nutrient deprivation has been proposed as an effective
approach to kill tumor cells [5]. After glucose withdrawal, reactive
oxygen species (ROS) are generated by mitochondrial dysfunction [6],
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but sometimes cancer cells evolved to avoid this metabolic stress by
mechanisms still unknown.
Glucose uptake is higher in tumor cells by an increase in protein
production and membrane translocation of facilitative glucose trans-
porters (GLUTs). Glucose uptake in cancer cells has been mainly asso-
ciated with GLUT1, which is overexpressed by growth factors and
usually correlates with cancer malignancy [7]. However, it may also
involve other GLUTs [8–10]. In addition to a drop in oxygen levels, the
core of a growing tumor also displays glucose starvation [11], and
nutrient removal alters expression or location of GLUT transporters. It
has been described that at least one of the GLUT isoforms is upregulated
in response to glucose deprivation in cancer cells [12]. Moreover, when
non-tumor cells are under growth factors deprivation, GLUT1 is usually
internalized and degraded in lysosomes. Consequently, glucose uptake
and metabolism dramatically decrease before cell death. Cancer cells
often overexpress GLUT1 in response to the absence of growth factors,
maintaining glucose metabolism and becoming resistant to apoptosis
[13].
In prostate cancer (PCa), glucose metabolism plays a major role in
progression [14]. Androgens can activate the metabolic regulator AMP-
activated kinase (AMPK), promoting oxidative phosphorylation (OX-
PHOS) [15]. Besides, androgens increase GLUT1 [16], which over-
production has been described in the most aggressive tumors [17,18].
Recently, our group described that this transporter is regulated by
compounds that block glucose uptake in PCa cells and prevent cancer
progression [19].
This work aimed to study the sensitivity of androgen-sensitive and
insensitive prostate cancer cells to nutrients deprivation and the pos-
sible role of GLUT1 on survival mechanisms of PCa cells after glucose
deprivation, a situation that occurs in the core of tumors.
2. Material and methods
2.1. Cell culture, transfection, and reagents
Human androgen-sensitive LNCaP cells were purchased from
European Collection of Cell Cultures (Catalog number 89110211,
Salisbury, UK) and were cultured in RPMI 1640 medium supplemented
with 10% FBS, 2mM L-glutamine, 15 mM HEPES, 100 μg/ml ampicillin
and 100 μg/ml kanamycin. PC-3 cells, a human androgen-insensitive
cell line, were purchased from American Type Culture Collection
(Catalog number CRL-1435, Manassas, VA, USA) and were grown in
DMEM/F12 medium supplemented with 10% FBS, 2% L-glutamine and
1% antibiotic-antimycotic cocktail (100 U/ml penicillin, 10 μg/ml
streptomycin and 0.25 μg/ml amphotericin B). Both cell lines were
authenticated by short tandem repeat (STR) profiling. Jurkat cells were
employed as a positive control in the study of GLUT1 surface levels
[20]. Cells were maintained in complete RPMI-1640 and DMEM/F12,
respectively. Cell lines were grown at 37 °C in a humidified 5% CO2
environment.
LNCaP-R cells, a clone of castration-resistant LNCaP were achieved
as previously described [21]. Briefly, LNCaP cells were grown in RPMI-
1640 supplemented with foetal bovine serum FBS was stripped from
small molecular weight molecules including steroids by incubation with
charcoal/dextran. For this purpose, FBS was incubated with a mixture
of 2.5% charcoal-activated plus 0.025% Dextran T70 overnight at 4 °C.
Charcoal/dextran-stripped FBS (FBSchst) was added to the culture
medium and filtered through a 0.22-µm sterile filter. Media plus FBSchst
were changed every other day. After 2 weeks, a massive cell death was
observed and only a small amount of cells survived. After a month,
isolated colonies were selected, subcultured in small 24-well plates and
left to grow all the time in the presence of FBSchst culture media. An-
drogen-resistant colonies were maintained and grew continuously for at
least 6 months. AR production in LNCaP-R was confirmed
(Supplementary Fig. S1A). AR cytosolic location and androgen-in-
sensitivity of LNCaP-R cells was proved (data not shown)
LNCaP or PC-3 GLUT1-overexpressing cells were obtained by using
FuGENE®HD (Promega Biotech Iberica S.L., Alcobendas, Madrid), fol-
lowing manufacturer's instructions. Plasmid pcDNA3.2/v5-DEST
hGLUT1 catalog number 18,085 (Addgene Europe, Teddington, UK)
nicely deposited by Wolf Frommer [22]. Cells were selected by in-
cubation with 300 μg/ml G418 (Sigma-Aldrich Quimica SL, Madrid,
Spain). GLUT1 overproduction in LNCaPGLUT1 and PC-3GLUT1 cells were
confirmed (Supplementary Fig. S1B). The increase in glucose uptake of
GLUT1-overexpressing cells was also confirmed (data not shown).
For all treatments, cells were left to attach for 48 h. Glucose con-
centration was always set at 2 g/L (11mM). For glucose/glutamine
deprivation assays, complete medium without glucose or glutamine was
purchased (Lonza Biologics Porriño SL, Barcelona, Spain). Fructose or
mannose (11mM) were added in the absence of glucose, and 2-deox-
yglucose (2DG) (10mM) (Alfa Aesar-Thermo Fisher, Karlsruhe,
Germany) was employed to disable glycolysis in the presence of glu-
cose.
Cell death was assayed by using 10 μM of the inhibitor of caspases q-
VD-OPH (Sigma-Aldrich Quimica SL, Madrid, Spain) was used to study
apoptosis, 100 μM necrostatin-1 to Receptor-Interacting serine/threo-
nine-Protein Kinase 1 (RIPK1)-dependent necroptosis, 25 μM necros-
tatin-7 to RIPK1-independent necroptosis, 2 μM ferrostatin-1 to fer-
roptosis and 2mM 3-methyladenine (3MA) to inhibit autophagy
(Cayman Chemical Hamburg, Germany). N-acetyl-cysteine (NAC) (Alfa
Aesar-Thermo Fisher, Karlsruhe, Germany), catalase, dehydroascorbic
acid (DHA) or (± )-6-Hydroxy-2,5,7,8-tetramethyl-chromane-2-car-
boxylic acid (Trolox) (Sigma-Aldrich Quimica SL, Madrid, Spain) were
employed as antioxidants. Hydrogen peroxide (H2O2) was used as
oxidant agent (Sigma-Aldrich Quimica SL, Madrid, Spain) and phloretin
was employed to inhibit GLUT1 transporter. All vehicles were adjusted
to the same concentration in each experimental group.
2.2. Trypan Blue exclusion
Cells were seeded in 6-well plates. After treatments, cells were
collected by scraping, centrifuged at 300×g for 5min and then sus-
pended in PBS. Total cells and dead cells were counted in 0.2% Trypan
Blue solution after 5min at RT.
2.3. Flow cytometry
Cell cycle was studied by staining with 50 μg/ml propidium iodide
(PI) and analyzed by flow cytometry. Apoptosis was quantified by
Annexin-V staining. Cells were reacted with annexin-V-fluorescein and
PI for 10min at RT following manufacturer's instructions (Immunostep
SL, Salamanca, Spain) and then, cells were analyzed. The percentage of
death cells corresponds to PI-positive cells and Annexin V/PI double
positive cells.
The production of GLUT1 and AR was also studied by flow cyto-
metry. For that, cells were fixed and permeability was performed by
incubation in methanol for 10min at RT. Cells were reacted against
anti-GLUT1 and anti-AR at RT for 30min (antibodies properties are
collected in Sup. Table 1) and then, they were stained with rabbit
secondary antibodies conjugated with Alexa Fluor 488 dye (Thermo
Fisher Scientific, Madrid, Spain) [23]. To detect nuclear AR, cells were
suspended in ice cold extraction buffer (320mM sucrose, 5 mM MgCl2,
10mM HEPES, 1% Triton X-100, pH 7.4) for 15min to isolate nuclei.
GLUT1 surface was monitored as a function of binding to the envelope
glycoprotein of the human lymphotropic virus (HTVL) HTLV was fused
to EGFP (HRBDEGFP, Metafora Biosystems, Montpellier, France), and it
was added to cells at a concentration 1:10 in PBS with 2%FBS as pre-
viously reported [20].
All samples were analyzed in a Cytomics FC500 flow cytometer
(Beckman Coulter), and data analysis was performed by using FlowJo
and Kaluza software.
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2.4. PAGE and immunoblotting
Total, cytoplasmic and nuclear proteins were obtained, separated
and electrotransferred as previously described [24]. For total protein
extraction, cells were lysed in RIPA lysis buffer (50mM Tris-HCl, pH
7.4, 150mM NaCl, 0.1% SDS, 1% Igepal C and 0.5% sodium deox-
ycholate) supplemented with 1mM Dithiothreitol (DTT) and a protease
inhibitor cocktail (10 μg/ml leupeptin, 2 μg/ml aprotinin A, 1 μg/ml
pepstatin, 200 μM sodium orthovanadate, 1 mM sodium fluoride and
1mM phenylmethylsulfonyl fluoride). To achieve cytoplasm and nu-
clear separation, cells were lysed in low-salt buffer (10mM HEPES-
KOH, 2mM MgCl2, 15mM NaCl, 0.1mM EDTA) containing 1mM DTT,
protease inhibitors and 0.2% Igepal C for 20min at 4 °C. Nuclear
fractions were collected by centrifugation at 14,000×g 5min at 4 °C
and supernatants (cytosolic fraction) were transferred to clean tubes.
Nuclear pellet was incubated with high-salt lysis buffer (420mM NaCl,
20 mM HEPES-KOH, 10mM KCl, 1 mM EDTA and 20% glycerol) sup-
plemented with 1mM DTT and protease inhibitors. After incubation on
ice for 15min, nuclear extracts were clarified by centrifugation at
13,000×g for 30min at 4 °C. Protein concentration was estimated using
Bradford protein assay (Bio-Rad Laboratories Inc., Madrid, Spain).
Antibodies (Sup. Table 1) were visualized by binding horseradish
peroxidase-conjugated anti-rabbit or anti-mouse (Santa Cruz Bio-
technology, Dallas, Tx, USA) secondary antibodies and detected with
chemiluminescence substrate (Millipore, Merck Chemicals & Life Sci-
ence SA, Madrid, Spain).
2.5. Glucose and glutamine uptake and glucose measurement in cell culture
medium
Glucose and glutamine uptake were assessed as described pre-
viously [25,26]. Briefly, 2DG uptake was initiated by the addition of
labeled 2-deoxy-D[1–3H] glucose to a final concentration of 2 μCi (1Ci
= 37 GBq). Glutamine uptake was initiated by the addition of labeled
L-2,3,4-[3H] glutamine (0.5 μCi). Incubation was performed for 10min
at RT. For standardization, cells were counted using a Neubauer he-
mocytometer chamber before each experiment. 2.5×105 LNCaP or
1.5×105 PC3 cells were employed in each assay.
2.6. Immunocytochemistry
Cells were fixed in phosphate buffered 2% paraformaldehyde pH
7.4. Samples were blocked by incubation with TBS (Tris-HCl 20mM pH
7.4, 150mM NaCl) plus 1% Bovine Serum Albumin (BSA) or 3% goat
serum and permeabilization was achieved by incubation with 0.15%
Tween-20 (cytoplasmic) or 0.1% TritonX-100 (nuclear) for 20min at
RT. Samples were studied under a under Leica TCS SP8 microscope
[19].
2.7. PSA levels
Prostate Specific Antigen (PSA) release was measured by ELISA
following manufacturer's instructions (Human Diagnostics, Wiesbaden,
Germany). Protein concentration was quantified by Bradford Assay for
standardization (Bio-Rad Laboratories Inc, Madrid, Spain).
2.8. ATP/AMP determination by HPLC
Cells were seeded in 100mm plate and harvested by scrapping at
70% confluence. After centrifugation at 500×g for 5min 4 °C, cell
pellets were dissolved in 0.3M perchloric acid and incubated 5min at
4 °C for protein precipitation. Samples were centrifuged at 9000×g for
5min, and supernatants were neutralized with 1M KOH. HPLC was
performed after centrifugation at 9000×g for 10min. Adenine nu-
cleotides (ATP, ADP, and AMP) were separated in a 15 cm × 4.6mm,
3mm SUPELCOSIL LC-18-T column (SUPELCO, Sigma-Aldrich Quimica
SL, Madrid, Spain) with a mobile phase composed of A mobile phase
(KH2PO4/tetrabutylammonium hydrogen sulfate –TBHS-, pH 6.0) and B
mobile phase (MeOH + TBHS, pH 5.5). Flow rate was set at 1.2 ml in a
gradient mode 0min (0%B), 2.5 min (0%B), 7min (20%B), 14min
(40%B), 19min (100%B), 24min (100%B), 27min (0%B). Nucleotides
were detected by UV absorption at 260 nm and identified and quanti-
fied by the comparison of retention time with standards. Protein con-
centration was quantified by Bradford Assay for standardization (Bio-
Rad Laboratories Inc, Madrid, Spain).
2.9. Detection of intracellular ROS levels
Cells were collected by trypsinization and washed twice with PBS.
The number of cells was adjusted to 5×105/sample. Total ROS levels
were measured incubating cells with 1 μM H2DCFDA (Bioquochem SL,
Llanera, Spain) for 15min at 37 °C. Mitochondrial O2.- was measured by
using MitoSOX (Fisher Scientific, Madrid, Spain). Cells were stained
with 5 μM MitoSOX at 37 °C for 15min. Cells were analyzed using a
Cytomics FC500 flow cytometer after staining. and data analysis was
performed by using Kaluza software.
2.10. H2O2 determination
First, cells were seeded in 6-well plate, and cell culture medium was
collected when cells reached at 70% confluence. Then, the medium was
centrifuged to eliminate cell debris. An electro-oxidation and ampero-
metric detection were employed for H2O2 determination as previously
described [24]. Screen-printed electrodes with co-phthalocyanine were
used as an electrochemical mediator (Bioquochem SL, Llanera, Spain).
Intensity (mA) was registered for 200 s employing +0.4 V as work
potential. Each sample was measured before and after adding 25 units
of catalase. Protein concentration was quantified by Bradford Assay for
standardization (Bio-Rad Laboratories Inc, Madrid, Spain).
2.11. SOD activity assay
Cell lysis was accomplished by freeze-thaw cycles in PBS and soni-
cation. Proteins were cleaned by centrifugation (12,000×g).
Superoxide dismutase (SOD) activity was performed following manu-
facturer's instructions (Sigma-Aldrich Quimica SL, Madrid, Spain).
Samples were treated with 5mM potassium cyanide 30min before the
assay to inhibit the activity of cytosolic CuZnSOD (SOD1) in order to
quantify mitochondrial SOD2 activity. Protein concentration was
quantified by using Bradford Assay for standardization (Bio-Rad
Laboratories Inc, Madrid, Spain).
Fig. 1. The response of LNCaP cells to glucose deprivation. (A-C) Annexin-V/PI assay of LNCaP and LNCaP-R cells after 48 h since glucose withdrawal.
Micrographs (A) and one representative experiment (B) are shown. Original magnification 200×. Results are expressed as % PI-positive cells (dead cells) (C). (D)
Trypan Blue results of LNCaP cells grown in absence of glucose and with 10 μM of the inhibitor of caspases q-VD-OPH, 100 μM of the inhibitor of necroptosis
necrostatin-1, 25 μM of the inhibitor of RIPK1-independent necroptosis necrostatin-7, 2 μM of the inhibitor of ferroptosis ferrostatin-1 or 2mM 3-methyladenine
(3MA) to inhibit autophagy. DMSO was added as vehicle. (E) Trypan Blue assay was performed in LNCaP cells grown in the absence of glucose, with 10mM 2DG or
under both conditions for 48 h (left panel). Representative micrographs are shown (right panel). Original magnification 200×. (F) Cell counting and viability by
trypan blue of LNCaP cells grown with 11mM (2 g/L) fructose (fru) or mannose (man) without glucose for 48 h. Representative micrographs are shown (right panel).
Original magnification 200×. Glucose concentration in control cells was always set at 2 g/L. Arbitrary 1.0 value was given to control cells. Results are expressed as
mean ± SEM (n=3). *p < 0.05 vs control; **p < 0.01 vs control; ***p < 0.001 vs control; #p < 0.05 vs w/o glu; ###p < 0.001 vs w/o glu. ΛΛΛp < 0.001 vs
2DG.
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Fig. 2. The regulation of GLUT1 under glucose deprivation in LNCaP cells. (A) 2DG uptake levels were evaluated in LNCaP and LNCaP-R cells grown in absence
of glucose for 24 h. (B) GLUT1 protein expression was determined by western-blot under the same conditions. (C) GLUT1 surface expression was studied by flow
cytometry. Levels were measured after 24 h since medium renewal. Jurkat cells were employed as a positive control. One representative experiment is shown. (D)
TXNIP, phosphoAMPKThr172 and AMPK protein levels were also analyzed by western-blot in cells grown without glucose for 24 h. Glucose concentration in cell
culture medium was always set at 2 g/L for control cells. In western-blot experiments, beta-actin was used as internal standard and one representative experiment is
shown. Results are expressed as mean ± SEM (n=3). *p < 0.05 vs control; **p < 0.01 vs control; ***p < 0.001 vs control.
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2.12. Native gel for determination of H2O2 depuration by catalase
H2O2 depuration by catalase (CAT) was determined as previously
described with minor modifications [27]. Briefly, protein samples were
obtained by lysing cells using freeze-thaw cycles in PBS and sonication.
Proteins were centrifuged (12,000×g) and quantified by Bradford
Assay (Bio-Rad Laboratories Inc, Madrid, Spain). 30 μg of cell extracts
were separated on a 6% native acrylamide gel, and CAT was de-
termined by incubating with 0.003% H2O2 for 10min and then adding
2% FeCl3 and 2% potassium ferrocianurum.
2.13. Thiol and disulfide assay
Thiol and disulfide assay was employed to measure total reduced
and oxidized glutathione (GSH and GSSG). Cells were seeded in 6-well
plates and collected at 70% confluence. Cells were harvested by
scraping, pelleted, and suspended in 50 μl of deproteinization buffer
(0.1% Triton X-100 in 5% sulfosalicylic). The assay was performed
following manufacturer's instructions (Bioquochem, Llanera, Spain).
Cell number was previously adjusted using a Neubauer counting
chamber for standardization.
2.14. Statistical analysis
Data are presented as a mean± standard error of the mean (SEM).
Differences were assessed using one-way ANOVA, followed by a
Student-Newman-Keuls (SNK) post-hoc ‘t′ test.
3. Results
3.1. Androgen-sensitive PCa cells are more resistant to cell death induced by
glucose deprivation than androgen-insensitive cells
Tumor heterogeneity is usually reflected by metabolic differences
within cancer cells, including the response to the limited source of
nutrients. Here, the response to glucose deprivation of androgen-sen-
sitive and insensitive cells was studied. LNCaP was employed as a
model of androgen-sensitive cells. Castration-resistant LNCaP-R, es-
tablished from LNCaP cells by growing in the absence of androgens for
at least 6 months, were used as a model of androgen-insensitive cells.
After glucose deprivation, cells showed morphological features
distinctive of cell death (Fig. 1A). Cell death was evaluated by dual
staining with fluorescent Annexin V and propidium iodide (PI) after
48 h of glucose removal. The number of Annexin V/PI positive cells are
shown in Fig. 1B-C. Androgen-insensitive LNCaP-R showed a higher
sensitivity to glucose deprivation compared to androgen-sensitive
LNCaP cells.
To determine the type of cell death caused by glucose withdrawal in
LNCaP cells, several pharmacologic compounds that inhibit different
types of cell death were tested in LNCaP cells (Fig. 1D). First, the pan-
caspase inhibitor q-VD-OPH was employed, but it was found that it did
not prevent cell death suggesting that, though annexin-V staining in-
creased after glucose removal, a type of caspase-independent cell death
is occurring. Necrostatin-1, an inhibitor of necroptosis via receptor-in-
teracting serine/threonine-protein kinase 1 (RIPK1), and necrostatin-7,
an inhibitor of RIPK1-independent necroptosis, did not prevent cell
death. Ferrostatin-1, an inhibitor of ferroptosis, and 3-methyladenine,
an inhibitor of autophagy, neither avoided cell death. Interestingly,
blocking autophagy by 3MA, cell death was enhanced under the ab-
sence of glucose. These results suggested that glucose deprivation in-
duces a non-apoptotic form of cell death as necrosis.
Once confirmed that cell death is driven by necrosis, it was studied
whether this response might have been dependent on glucose avail-
ability or it was a general response to glycolysis interruption. Then,
2DG, an analog of glucose that does not follow glycolysis, was assayed
in the presence of glucose. Fig. 1E shows that 2DG did not induce death
in LNCaP cells. This result implies that the availability of glucose, and
not a metabolite derived from glycolysis, is crucial for PCa survival.
Since glucose absence, but not the inhibition of glycolysis is re-
sponsible for cell death in LNCaP cells, it was studied whether another
sugar source such as fructose or mannose would be able to prevent cell
death. Cells cultivated in the presence of fructose and mannose did not
die and still grew even under glucose deprivation (Fig. 1F), suggesting
that it is sugar deprivation, the responsible for cell death.
In addition to glucose, glutamine is one of the essential nutrients of
PCa cells. First, the balance in the uptake of glutamine in the absence of
glucose was studied. After glucose removal, an increase in glutamine
uptake was not found in LNCaP cells, and it was significantly reduced in
LNCaP-R cells (Supplementary Fig. S2A), suggesting that the absence of
glucose did not affect to glutamine uptake. Moreover, the removal of
glutamine did not have any significant relevance in cell survival, since
cells did not die in the absence of glutamine when glucose is present
(Supplementary Fig. S2B).
3.2. Glucose withdrawal upregulates GLUT1 in androgen-sensitive prostate
cancer cells
Since glucose uptake seemed to be essential for the survival of PCa
cells, the role of glucose transportation in cell survival was studied.
First, the rate of 2DG, an analog of glucose that enters the cell by using
GLUT transporters and accumulates inside cells was examined. As
shown, LNCaP cells significantly increased 2DG uptake after glucose
removal (Fig. 2A) proposing an increment of GLUT transporters.
Since GLUT1 is the major transporter of glucose in PCa cells, we
investigated whether an increment of total protein levels or an increase
in the surface location of GLUT1 occurred after glucose removal.
GLUT1 production increased in androgen-sensitive LNCaP cells, but it
was significantly down-regulated by glucose deprivation in androgen-
insensitive LNCaP-R cells (Fig. 2B). To confirm if the uptake increment
was related to surface GLUT1 levels, FACS analysis was performed.
Interestingly, glucose deprivation increased total surface GLUT1 in both
LNCaP and LNCaP-R cells (Fig. 2C).
The increment of GLUT1 production in androgen-sensitive LNCaP
cells suggested the participation of androgen signaling in the me-
chanism of cell response to glucose deprivation. To confirm a possible
role of androgens in response to glucose deprivation, GLUT1 protein
levels were studied in LNCaP cells when they were cultured after glu-
cose removal for 24 h in a steroid-depleted medium FBSchst.
Interestingly, GLUT1 levels decreased by half in LNCaP cells cultured in
androgen-depleted media, and they did not increase after glucose de-
privation contrary to the findings observed in complete media in the
presence of androgens (Supplementary Fig. S3). These results suggested
Fig. 3. The effect of glucose deprivation in AR signaling. (A) Immunocytochemical analysis of AR in LNCaP cells glucose-deprived for 24 h. Cells were incubated
with a secondary antibody conjugated with phycoerythrin (red fluorescence) and then counterstained with DAPI (blue fluorescence). A representative picture is
shown. (B) Nuclear (Nuc) and cytoplasmic (Cyto) AR protein levels were determined by western-blot using the same experimental conditions. beta-actin was used as
cytoplasmic internal standard while HDAC2 was used as a nuclear internal standard. Nuclear/cytoplasmic AR ratio was determined. One representative experiment is
shown. The experiment was performed 3 times (C) PSA levels in culture medium without glucose were determined by ELISA measurement. Results were standardized
to protein concentration (ng PSA/μg protein). (D) GLUT1, total AR and nuclear AR protein production along cell cycle. Cells were incubated with a secondary
antibody conjugated with AlexaFluor488 and then with Propidium iodide (PI) are shown in lower panels. Negative controls (C-), unstained cells, are shown in upper
panels. Fluorescence was measured by flow cytometry. One representative of three different experiments is shown. Glucose concentration was always set at 2 g/L in
control cells. Arbitrary 1.0 value was given to control cells and results are expressed as mean ± SEM (n=3) in all experiments. ***p < 0.001 vs control.
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Fig. 4. The effect of glucose deprivation on redox balance. (A) ATP/AMP ratio was determined by measuring ATP and AMP levels by HPLC in LNCaP after 24 h
since glucose withdrawal. (B) H2O2 was measured in cell culture medium (left panel) and (C) mitochondrial superoxide was determined by MitoSOX Red® staining
(right panel) in glucose-deprived LNCaP cells after 24 h since medium renewal. (D) Trypan Blue results (left panel) and representative micrographs (right panel) of
LNCaP grown in absence of glucose for 48 h and with 5mM N-acetylcysteine (NAC), 100 μM dehydroascorbic acid (DHA), 100 μM Trolox or 50 U/ml catalase (CAT).
DMSO was added as vehicle. Original magnification 200×. (E) Nuclear (Nuc) and cytoplasmic (Cyto) AR protein levels were determined by western-blot in LNCaP
treated with 10 μM H2O2 for 24 h. Beta-actin was used as cytoplasmic internal standard while HDAC2 was used as a nuclear internal standard. Following the same
conditions, phosphoAMPKThr172, AMPK and GLUT1 were also analyzed by western-blot. Beta-actin was used as internal standard. One representative experiment is
shown. Glucose concentration in control cells was always set at 2 g/L. Arbitrary 1.0 value was given to untreated cells. Results are expressed as mean± SEM (n=3).
*p < 0.05 vs control; ***p < 0.001 vs control; ###p < 0.001 vs. w/o glu.
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that androgens have to be present to increase GLUT1 after glucose re-
moval.
It has been previously described that AMP-activated protein kinase
(AMPK) regulates production and membrane location of GLUT1 and it
is activated by androgens. To explore whether AMPK would be related
to the increment of GLUT1 production and membrane translocation
after glucose withdrawal in androgen-sensitive cells, the phosphoryla-
tion of AMPK was studied in both androgen-sensitive and insensitive
PCa cells. Phospho-AMPKThr172 levels were increased under glucose
deprivation in androgen-sensitive LNCaP cells, but this increase was not
significant in castration-resistant LNCaP-R cells (Fig. 2D). The produc-
tion of Thioredoxin Interacting Protein (TXNIP), an AMPK-regulatory
inhibitor described as a possible link between cellular redox state and
metabolism, was also studied. Interestingly, TXNIP decreased under
glucose deprivation in both cell types, being this reduction was much
more significant in androgen-sensitive LNCaP cells.
3.3. Glucose removal increases AR activity
Since GLUT1 increased after glucose removal only in the presence of
androgens, we assessed the role AR signaling on GLUT1 production. It
was first found that glucose removal promoted an increment of AR
mainly restricted to the nuclear compartment when observed under
confocal microscopy (Fig. 3A) or analyzed by western-blot analysis
(Fig. 3B). As expected, nuclear translocation was associated with a
higher AR activity measured via the release of PSA (Fig. 3C).
Androgens and AR signaling are necessary for prostate maintenance
and homeostasis, and they are the principal regulators of cancer cells
proliferation in the prostate. Since AR activity was increased after
glucose deprivation, GLUT1 and AR protein abundance across cell cycle
were studied by flow cytometry (Fig. 3C). As expected total and nuclear
AR increased in S and G2/M phases in LNCaP cells, but more im-
portantly it correlated with GLUT1 because it is also enhanced in S and
G2/M phases. These results suggested a concomitant overexpression of
Fig. 5. The effect of GLUT1 overexpression in glucose-deprived LNCaP cells. LNCaPMock and LNCaPGLUT1 cells were employed for all experiments. (A)
Representative micrographs after 48 h since glucose withdrawal (left panel). Original magnification 200×. Cell death was analyzed by PI staining. Results are
expressed as % PI-positive cells (dead cells). Glucose concentration in control cells was always set at 2 g/L. Arbitrary 1.0 value was given to control cells. Results are
expressed as mean ± SEM (n=3). (B) Trypan Blue assay in cells treated with 15 μM H2O2 for 48 h (right panel). Representative micrographs are shown (left panel).
Original magnification 200×. (C) Representative micrographs (left panel) and Trypan Blue assays of cells treated with 100 μM phl in cell culture medium without
glucose for 48 h. *p < 0.05 vs control; **p < 0.01 vs control cells; ***p < 0.001 vs control cells; #p < 0.05 vs LNCaPMock cells; ###p < 0.001 vs LNCaPMock cells.
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AR and GLUT1 along with cell cycle in androgen-sensitive prostate
cancer cells.
3.4. Cell death driven by glucose deprivation is dependent on oxidative
stress in PCa cells
Necrosis cell death is usually associated with a decrease of ATP
production and an increase of free radicals. For this reason, the role of
redox signaling in cell death caused by nutrients deprivation was con-
sidered. First, glucose deprivation significantly reduced ATP/AMP ratio
as expected (Fig. 4A) and it also increased H2O2 production (Fig. 4B)
and mitochondrial superoxide (Fig. 4C). To confirm that an oxidative
pathway contributed to cell death induced by glucose deprivation in
LNCaP cells, N-acetyl-L-cysteine (NAC), 6-hydroxy-2,5,7,8-tetra-
methylchroman-2-carboxylic acid (TROLOX), dehydroascorbic acid
(DHA) or catalase (CAT) were added to cell culture medium after glu-
cose removal. As shown in Fig. 4D, the incubation with NAC or catalase,
significantly prevented cell death triggered by glucose deprivation.
However, DHA or TROLOX did not have any effect. These results cor-
roborate the involvement of oxidative pathways in nutrients
deprivation induced cell death of androgen-sensitive prostate cancer
cells.
Given that glucose deprivation caused the upregulation of GLUT1 in
LNCaP cells, the relation between free radicals and GLUT1 production
in PCa cells was studied. LNCaP cells were incubated with 10 µM H2O2
for 24 h. After treatment, translocation of AR, phosphorylation of AMPK
and GLUT1 production was investigated. H2O2 increased nuclear AR
translocation as well as the activation of phosphor-AMPKThr172 and, and
then, it elevated GLUT1 production (Fig. 4E). Since after glucose re-
moval H2O2 increased, H2O2 might be responsible for AR activation and
in turn, of the increment of GLUT1 after glucose withdrawal.
3.5. GLUT1 overexpression protects from glucose deprivation-induced cell
death in LNCaP cells
To assess the role of GLUT1 in cell death after glucose deprivation in
LNCaP cells, the sensitivity to glucose removal and free radicals after
the overexpression of GLUT1 in LNCaP cells was studied.
We studied the redox phenotype of GLUT1-overexpressing LNCaP
cells since they should consume more glucose and then, they should
Fig. 6. The role of GLUT1 overexpression in the response of glucose deprivation-induced oxidative stress in LNCaP cells. LNCaPMock and LNCaPGLUT1 cells
were employed for all experiments. Cell were glucose-starved for 24 h. (A) SOD1, SOD2, CAT, GPX1 and TRX1 protein production were analyzed by western-blot.
Beta-actin was employed as internal standard and one representative experiment is shown. Only proteins with significant differences are graphically represented. (B)
Total SOD and SOD2 activity were determined by enzymatic assay. (C) H2O2 depuration by CAT was determined by native acrylamide gel. One representative
experiment is shown. (D) GSH/GSSG ratio was determined by enzymatic assay. Glucose concentration in control cells was set at 2 g/L. An arbitrary value of 1.0 was
given to control cells. Results are expressed as mean ± SEM (n=3). *p < 0.05 vs control cells; ***p < 0.001 vs control cells; #p < 0.05 vs LNCaPMock cells;
###p < 0.001 vs LNCaPMock cells.
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Fig. 7. The response of PC-3 cells to
glucose deprivation. (A) Annexin-V/PI
assay of PC-3 cells after 48 h since glu-
cose withdrawal. Micrographs and one
representative experiment are shown
(left panel). Original magnification
200×. Results are expressed as % PI-
positive cells (dead cells). (A) Trypan
Blue results of PC-3 cells grown in the
absence of glucose, with 10mM 2DG or
under both conditions for 48 h (left
panel). Representative micrographs are
shown (right panel). Original magnifi-
cation 200×. (B) Cell counting and
viability by trypan blue of LNCaP and
PC-3 cells grown with 11mM (2 g/L)
fructose (fru) or mannose (man)
without glucose for 48 h.
Representative micrographs are shown
(right panel). Original magnification
200×. (D) GLUT1 protein levels were
determined by western-blot in PC-3
cells grown without glucose for 24 h.
beta-actin was used as internal standard
and one representative experiment is
shown. Glucose concentration in con-
trol cells was always set at 2 g/L.
Arbitrary 1.0 value was given to control
cells. Results are expressed as
mean ± SEM (n=3). *p < 0.05 vs
control; ***p < 0.001 vs control;
###p < 0.001 vs w/o glu.
ΛΛΛp < 0.001 vs 2DG.
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Fig. 8. The protective effect of GLUT1 overexpression in androgen-insensitive PC-3 cells. PC-3Mock and PC-3GLUT1 cells were employed for all experiments. (A)
Representative micrographs of cells grown without glucose for 48 h are shown (original magnification 200×) (left panel). The percentage of death cells (PI positive)
is compared (n= 3). (B) Trypan Blue assay in cells treated with 10mM H2O2 for 48 h. Representative micrographs are shown (original magnification 200×) (right
panel). (C) SOD2 and GPX1 protein production were analyzed by western-blot. Beta-actin was employed as internal standard and one representative experiment is
shown. (D) Total SOD and SOD2 activity were determined by enzymatic assay. (E) H2O2 depuration by CAT was determined by native acrylamide gel. One
representative experiment is shown. (F) GSH/GSSG ratio were determined by enzymatic assay. Glucose concentration in control cells was set at 2 g/L. An arbitrary
value of 1.0 was given to control cells. Results are expressed as mean ± SEM (n=3). ***p < 0.001 vs control cells; ###p < PC-3Mock cells.
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have a more oxidative phenotype. Interestingly GLUT1 overexpression
did not cause any increment of free radicals in LNCaP cells
(Supplementary Fig. S4A, B). Moreover, it did not increase H2O2 or
mitochondrial superoxide after glucose removal in LNCaP cells
(Supplementary Fig. S4C, D).
LNCaP cells overexpressing GLUT1 showed a lower sensitivity to
glucose removal then LNCaP cells, as showed in Fig. 5A. Moreover,
GLUT1 overexpression protects cells from H2O2 toxicity. Thus, cells
were incubated with 15 µM H2O2 for 48 h, LNCaPGLUT1 cells were more
resistant to H2O2 toxicity than LNCaP cells (Fig. 5B).
To confirm whether GLUT1 protection is due to an extracellular
signal uptaken by the transporter or an intracellular signaling pathway
promoted by GLUT1 overexpression, GLUT transporters were blocked
by using phloretin, a natural product that has been used as a specific
inhibitor of GLUT1 [19]. By blocking GLUT1 with phloretin cell death
was enhanced in LNCaP and LNCaPGLUT1 cells after glucose deprivation
(Fig. 5C). Furthermore, LNCaP and LNCaPGLUT1 cells were grown in low
serum media to confirm whether a component of serum would parti-
cipate in the role of glucose transporters in survival (Supplementary
Fig. S5). Interestingly, as previously demonstrated, GLUT1 protected
from cell death caused by depletion of growing factors induced by
cultivation with 1% FBS even in the presence of glucose. However,
under glucose removal in low serum incubation, ectopic overexpression
of GLUT1 did no protect androgen-dependent prostate cancer cells.
3.6. GSH levels are stimulated in GLUT1-overexpressing LNCaP cells after
glucose removal
Since the increment of GLUT1 makes cells more resistant to glucose
deprivation and oxidative stress, the role of antioxidant pathways in
survival after ectopic overexpression of GLUT1 was investigated.
First, total protein levels of the antioxidant enzymes SOD1, SOD2,
CAT, glutathione peroxidase 1 (GPX1) and thioredoxin 1 (TRX1) were
studied in LNCaP and LNCaPGLUT1 cells. After glucose removal, SOD2
protein levels diminished significantly, and its levels recover to controls
by GLUT1 overexpression. Also, GPX protein production was increased
in both LNCaP and LNCaPGLUT1 cells (Fig. 6A). However, no differences
in SOD/SOD2 activity was found (Fig. 6C) and CAT activity increased in
both LNCaP and LNCaPGLUT1 cells (Fig. 6A, C). Of all parameters in-
vestigated, GLUT1 overexpression significantly increased reducing
power of cells by increasing GSH/GSSG ratio in LNCaPGLUT1 cells after
glucose removal (Fig. 6D). This suggests that overexpression of GLUT1
might protect from glucose deprivation by increasing the reducing
power inside cells.
3.7. GLUT1 also prevents cell death induced by glucose deprivation
androgen-insensitive prostate cancer cells
To support that GLUT1 overexpression by itself has a role in the
survival of PCa cells, we studied the answer to glucose deprivation of
androgen-insensitive PC-3 cells, which do not produce AR or respond to
androgens. First, it was found that PC-3 cells died after glucose depri-
vation (Fig. 7A). This effect was not dependent on glycolysis disruption
since 2DG treatment did not alter cell viability, likewise androgen-
sensitive LNCaP cells (Fig. 7B). Also, and also parallel to LNCaP, fruc-
tose and mannose supplementation in cell culture medium prevented
cell death caused by glucose deprivation in PC-3 cells (Fig. 7C). How-
ever, contrary to LNCaP cells, GLUT1 protein levels did not increase in
glucose-deprived cells (Fig. 7D). The fact that would confirm the ne-
cessity of an active form of AR to achieve an increment of GLUT1
production after glucose removal.
When we ectopically overexpressed GLUT1 in PC-3 cells, the death
induced by glucose deprivation (Fig. 8A) and the toxicity of H2O2 were
also prevented. Besides, glucose removal also MitoSOX® staining in PC-
3 cells confirming the increase of oxidative stress (data not shown).
In PC-3, after glucose removal there was an increased in GPX1 or
SOD2 production in both native or overexpressing GLUT1 cells and a
significant decrease in SOD2 activity was also found in PC-3 after
glucose removal. Contrary to LNCaP, androgen insensitive PC-3 and PC-
3GLUT1 cells showed a reduction of catalase activity after glucose re-
moval.
Finally, after glucose deprivation, there was a significant reduction
in GSH/GSSG balance in PC-3 cells that was recovered by GLUT1
overexpression (Fig. 8F).
Collectively, these data indicate that GLUT1 overexpression with-
stands glucose deprivation by a higher resistance to oxidative stress,
events that might be directly related to a higher resistance to cell death.
4. Discussion
Cancer cells are characterized by an increase in glucose uptake and
glycolysis. Therefore, targeting glucose metabolism is suggested as a
promising approach in oncology. In this report, it is described for the
first time that GLUT1 overproduction protects cells from cell death
caused by glucose deprivation by an antioxidant mediated mechanism.
Glucose concentration inside the tumor core, away from blood
vessels, vary from 0.25 to 2.5 mM [28], lower than in normal tissues.
Together with hypoxia, glucose deprivation causes tumor cells to adapt
their metabolism. Results shown here confirmed that cell death trig-
gered by glucose deprivation does not follow the classical apoptotic
response through caspase activation, necroptosis, ferroptosis or autop-
hagy. We proved as previously demonstrated in other cell types that
glucose removal activates necrosis [5]. Interestingly, we found that
2DG does not induce cell death in PCa cells, through glycolysis is not
active. It would be possible that the treatment with 2DG could be
promoting survival from autophagy in PCa, as it was previously de-
scribed [29,30].
It is well known that glucose deprivation cytotoxicity is mediated by
oxidative stress in other cell types [6]. Some studies proposed that ROS
induced by glucose deprivation are due to a promotion of mitochondrial
metabolism in detriment of glycolysis [31,32]. However, in some cell
lines, cell death cannot be prevented with antioxidants [33,34]. Here,
glucose starvation increases both, H2O2 and mitochondrial superoxide
and antioxidants such as NAC or catalase can prevent cell death. NAC
maintains reduced glutathione levels and catalase depurates H2O2.
However, DHA does not prevent cell death in PCa, and this might be
due to the cost in GSH since GSH is required by cells to regenerate
ascorbic acid [35].
Although glucose metabolism has not been considered as important
as lipid or protein metabolism in PCa, it has been confirmed that glu-
cose is essential for cell proliferation and survival [36]. In addition to
glucose, glutamine is necessary for cell growth and proliferation of PCa
cells [37], but surprisingly LNCaP cells do not die after glutamine de-
privation. Interestingly, other sugars like fructose or mannose, also
internalized by GLUT transporters, prevent cell death and diminish
proliferation under glucose withdrawal perhaps because they replace
glucose at any other point in the metabolic network.
Glucose metabolism in PCa is different when compared to other
carcinomas. In non-pathological tissue, the prostate gland is primarily
glycolytic because of a defect in tricarboxylic acid (TCA) cycle [38].
However, at the beginning of carcinogenesis, the gland becomes OX-
PHOS-dependent and then, in more aggressive stages, tumors become
again to turn to glycolysis [39]. Therefore, resistance to glucose de-
privation in PCa cells is different at the beginning or later stages of the
disease. In fact, castration-resistant LNCaP-R cells are more sensitive to
glucose starvation than parental LNCaP cells, indicating their higher
dependence on glucose [40]. It was previously reported that cells de-
ficient in upregulating OXPHOS are more sensitive to glucose depri-
vation [41], which it may be related to our results.
In the absence of glucose, cells usually overexpress an isoform of
GLUT transporters [12]. Here it is shown that PCa cells with functional
AR increase the levels of GLUT1 after glucose deprivation. It was
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previously described that GLUT1 regulation is dependent on AR activity
[42]. Throughout carcinogenesis, the expression of this transporter is
also differentially regulated. The healthy prostate produces GLUT1,
decreasing its levels at early stages during tumor progression [43].
However, in most aggressive tumors, GLUT1 is found overexpressed,
concomitant with a higher glycolytic activity and hypoxia [17].
Interestingly, when glucose is deleted in PCa cells, GLUT1 is in-
creased. Also, AR is almost entirely located in the nucleus, correlating
with the increment in GLUT1 levels. These results are in agreement
with those reported by Vaz et al. [16], They described an increase in
GLUT1 after DHT stimulation [16]. Furthermore, glucose deprivation
fails to enhance GLUT1 expression when cells are grown in the absence
of androgens. Hyperglycemia downregulates AR levels in Type 2 dia-
betes. Interestingly, diabetes type 2 is inversely related to prostate
cancer incidence [44]. On the other hand, low glucose stimulates
GLUT1 production, which might be concerned with the promotion of
more aggressive tumors. Nuclear AR translocation, and consequently
GLUT1 enhancement, are directly associated with cell proliferation.
Since both proteins are found during S and G2/M cell cycle phases, they
could act synergistically to promote cell proliferation under androgenic
stimulation or suppressing cell cycle arrest in the absence of glucose. On
the contrary, it is known that glycolysis only affects cell cycle dis-
tribution from G1 to S [45].
In PCa, AMPK is considered a key metabolic regulator involved in
proliferation and cell survival [46]. In PCa, androgens stimulate AMPK
activation leading to OXPHOS [15]. AMPK is also able to induce GLUT1
expression and membrane translocation by inhibiting TXNIP [47], in-
dicating that GLUT1 overexpression via AMPK can protect from cell
death caused by glucose deprivation. More interestingly, H2O2 stimu-
lates glucose uptake in cells overexpressing GLUT1 [48]. Accordingly,
with these results, H2O2 increases nuclear AR levels and GLUT1 pro-
duction via AMPK in LNCaP cells. The protective activation of AMPK by
H2O2 has been already described, and recently it was proposed as a
regulator of mitochondrial ROS [49,50].
In PCa cells that overexpress GLUT1, as expected, glucose con-
sumption is higher than in parental cells. Recent studies showed that
the overexpression of GLUT1 drives with an inflammatory response
because of the increase of ROS in macrophages due to a higher glucose
uptake [51,52]. Here it is shown that oxidative stress is enhanced in
GLUT1-overexpressing cells in the presence of glucose, but not under
glucose deprivation.
To determine the mechanism by which GLUT1 protects cells from
glucose removal, and given the oxidative signal caused by glucose re-
moval, we analyzed several antioxidant pathways. The activity of mi-
tochondrial SOD2, that fall after glucose removal in LNCaP cells, is
sustained under glucose deprivation in GLUT1-overexpressing cells.
Recently, it was described a role of this enzyme in the survival of renal
carcinoma cells, as well as, in the promotion of cell proliferation of lung
cancer cells via AMPK [53,54].
Mainly GLUT1 overexpression increases reduced levels of glu-
tathione. Since pentose phosphate pathway is not overstimulated after
glucose withdrawal, the necessary NADPH to maintain GSH has to
come from the mitochondria mainly. It was recently published that
nicotinamide phosphoribosyltransferase (NAMPT), involved in NAD+
biosynthesis, protects cells from glucose deprivation-induced oxidative
stress and that it is also regulated by AMPK [55], which confirms the
role of mitochondria as the source of reducing power.
The protective role of GLUT1 in PCa cells may come from the uptake
of some compound included in culture medium or by the activation/
inhibition of an intracellular signaling pathway. Besides glucose uptake,
it is well-known that GLUT1 can transport other compounds. The
treatment with phloretin, which is well-established as a GLUT blocker
[56] enhances cell death by glucose deprivation, implying that this
response is not only a consequence of intracellular signaling. The in-
crease of cell death by serum deprivation strengthens this idea. More-
over, it was recently described that ROS production is enhanced in L6
myoblasts when GLUT1 is inhibited by phloretin, which it is in agree-
ment with our results [57].
5. Conclusions
GLUT1 acts as an oncoprotein in several tumors. However, it does
not only promote proliferation because of increasing glucose uptake; it
has a significant protective role against nutrients deprivation. Glucose
starvation rises oxidative stress that in turn activates AR activity and, as
a consequence, AMPK signaling and GLUT1 production. After GLUT1
increment, GSH levels rise protecting PCa cells from cell death. In PCa,
GLUT1 is usually overexpressed in highly aggressive tumors so that it
might protect cancer cells from low glucose microenvironments.
Altogether, these results show the importance of glucose availability
and glucose transporter for PCa survival and its relation to redox sig-
naling.
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